```html

Xanthine‑Induced Cough

What is Xanthine‑induced Cough?

Xanthine‑induced cough is a dry, often irritating cough that occurs as a side‑effect of medications containing xanthine derivatives such as theophylline, aminophylline, and caffeine‑based bronchodilators. Xanthines are a class of compounds that relax smooth muscle in the airways, increase diaphragmatic contractility, and stimulate the central respiratory centre. While therapeutic at appropriate doses, excessive serum levels can irritate the respiratory mucosa, provoke reflex bronchoconstriction, and trigger a cough reflex. The condition is most commonly seen in patients with asthma, chronic obstructive pulmonary disease (COPD), or sleep‑disordered breathing who are prescribed theophylline for long‑term control.

The cough is typically non‑productive (dry) and may worsen at night or after physical exertion. It can be mistaken for a flare‑up of the underlying lung disease, leading to unnecessary escalation of inhaled steroids or antibiotics if the drug‑induced cause is not recognized.

Common Causes

Below are the most frequent reasons a patient may develop a xanthine‑related cough:

• Theophylline toxicity – serum level > 20 µg/mL (often due to dosing errors, drug interactions, or renal/hepatic impairment).
• Aminophylline infusion – rapid IV bolus or high‑dose continuous infusion in intensive‑care settings.
• High‑dose caffeine tablets – over‑the‑counter stimulant pills can reach xanthine concentrations that irritate the airway.
• Combination therapy – concurrent use of theophylline with macrolide antibiotics, fluoroquinolones, or certain antidepressants that inhibit CYP1A2 metabolism.
• Renal insufficiency – reduced clearance leads to accumulation of the drug.
• Hepatic disease – impaired metabolism (e.g., cirrhosis) raises systemic levels.
• Smoking – nicotine induces CYP1A2, causing fluctuating theophylline levels and airway irritation.
• Dehydration – concentrates the drug in plasma, increasing the risk of cough and other side‑effects.
• Genetic polymorphisms – variations in CYP1A2 or ABCB1 genes affect drug clearance.
• Acute illness – fever, infection, or inflammation can transiently reduce theophylline clearance.

Associated Symptoms

When the cough is driven by xanthine excess, several other signs often appear:

• Palpitations or tachycardia
• Headache (often described as “migraine‑like”)
• Nausea, vomiting, or abdominal discomfort
• Restlessness, insomnia, or anxiety
• Tremor or muscle twitching
• Chest tightness that improves when the medication is held
• Rapid breathing (tachypnea) without hypoxia
• Rarely, seizures or arrhythmias in severe toxicity

When to See a Doctor

Prompt medical evaluation is advised if any of the following occur:

• New or worsening cough that started after beginning or changing dose of a xanthine medication.
• Associated symptoms such as palpitations, headache, nausea, or tremor.
• Persistent cough that interferes with sleep, work, or daily activities.
• Signs of theophylline toxicity (e.g., heart rhythm irregularities, seizures).
• Any respiratory symptom that does not improve after 48 hours of dose adjustment.
• Pregnancy or breastfeeding – xanthine exposure can affect the fetus or infant.

Patients with pre‑existing heart disease, uncontrolled asthma, or chronic kidney disease should contact their provider sooner, as the therapeutic window for xanthines is narrow.

Diagnosis

Diagnosing a xanthine‑induced cough involves a systematic approach:

1. Detailed Medication History

• Record brand name, dose, frequency, and duration of all xanthine‑containing products.
• Identify recent changes, missed doses, or use of over‑the‑counter caffeine supplements.

2. Review of Concomitant Drugs

• Check for CYP1A2 inhibitors (e.g., ciprofloxacin, fluvoxamine) or inducers (e.g., smoking, carbamazepine).

3. Laboratory Tests

• Theophylline serum level – drawn 6‑8 hours after the last dose (peak level). Therapeutic range: 10–20 µg/mL.
• Basic metabolic panel – assess renal function (creatinine, BUN).
• Liver function tests – rule out hepatic impairment.

4. Pulmonary Examination

• Listen for wheezes, rhonchi, or crackles that might suggest an alternative cause.
• Spirometry may be ordered to differentiate from asthma/COPD exacerbation.

5. Imaging (if needed)

• Chest X‑ray or CT scan to exclude infection, pneumonia, or malignancy when cough persists despite normal drug levels.

Treatment Options

Management focuses on removing the offending agent, alleviating symptoms, and preventing recurrence.

1. Discontinue or Adjust the Xanthine

• For mild toxicity, reduce the dose by 25‑50 % and re‑check serum level after 48 hours.
• In moderate‑to‑severe toxicity, stop the drug temporarily and consider an alternative bronchodilator (e.g., long‑acting β2‑agonist).

2. Symptomatic Relief

• Honey‑based lozenges or warm tea can soothe a dry cough (per CDC recommendations).
• Short‑acting bronchodilators (albuterol) may ease associated bronchospasm.
• Non‑sedating antihistamines (e.g., loratadine) if upper‑airway irritation is present.

3. Pharmacologic Intervention for Toxicity

• Activated charcoal (single dose) if ingestion was within 1‑2 hours and the patient is alert.
• Intravenous bicarbonate in cases of severe theophylline poisoning to alkalinize urine and enhance excretion (used under ICU supervision).
• Hemodialysis for life‑threatening levels (> 100 µg/mL) or refractory arrhythmias.

4. Monitoring

• Repeat theophylline levels every 12 hours until within therapeutic range.
• Continuous cardiac monitoring for arrhythmias in moderate‑to‑severe cases.

5. Long‑Term Alternatives

• Inhaled corticosteroids + long‑acting β2‑agonists for asthma control.
• LAMA (long‑acting muscarinic antagonist) agents for COPD.
• Low‑dose theophylline (< 200 mg/day) with therapeutic drug monitoring if the drug remains necessary.

Prevention Tips

• Use the lowest effective dose. Start at the smallest dose and titrate slowly.
• Adhere to scheduled blood‑level checks. Most clinicians order a level after 1–2 weeks of therapy and after any dose change.
• Avoid drug interactions. Inform your provider of antibiotics, antidepressants, or herbal supplements you are taking.
• Stay hydrated. Adequate fluid intake helps maintain stable plasma concentrations.
• Monitor kidney and liver function annually or more frequently if you have chronic disease.
• Limit caffeine. Reduce coffee, energy drinks, and over‑the‑counter stimulants while on a xanthine medication.
• Report symptoms early. A mild cough today can prevent a severe toxicity episode tomorrow.
• Consider genetic testing if you have a history of unusual drug reactions; some labs can screen for CYP1A2 polymorphisms.

Emergency Warning Signs

Key Take‑aways

Xanthine‑induced cough is an often‑overlooked adverse effect of theophylline and related drugs. Recognition hinges on a careful medication review, serum level testing, and awareness of potential drug interactions. Most cases resolve with dosage adjustment or discontinuation, but severe toxicity can be life‑threatening and requires urgent medical attention. By staying informed, adhering to monitoring schedules, and reporting new respiratory symptoms promptly, patients can safely benefit from xanthine therapy while minimizing cough and other side‑effects.

References:

• Mayo Clinic. “Theophylline (Oral Route).” Mayoclinic.org. Accessed May 2026.
• CDC. “Cough: When to Seek Medical Care.” CDC.gov. 2023.
• NIH National Library of Medicine. “Theophylline Toxicity.” PubMed. 2020.
• World Health Organization. “Pharmacovigilance: Monitoring Drug Safety.” WHO Publications, 2022.
• Cleveland Clinic. “Bronchial Asthma: Managing Medications.” clevelandclinic.org. 2024.

```